Molecular Pharmacology Fast Forward. Published on April 2, 2020 as DOI: 10.1124/mol.119.118539 This article has not been copyedited and formatted. The final version may differ from this version. MOL # 118539 Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer Vivian W.Y. Liao,# Anuradha Kumari,# Rajeshwar Narlawar, Soma Vignarajan, David E. Hibbs, Dulal Panda, and Paul W. Groundwater Downloaded from Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, molpharm.aspetjournals.org NSW 2006, Australia (VWYL, RN, DEH, PWG); Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai 400076, India (AK, DP); Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia (SV) at ASPET Journals on September 26, 2021 1 Molecular Pharmacology Fast Forward. Published on April 2, 2020 as DOI: 10.1124/mol.119.118539 This article has not been copyedited and formatted. The final version may differ from this version. MOL # 118539 Running Title: Novel Tubulin-Binding 3,5-Bis(styryl)pyrazoles Corresponding authors: Paul W GROUNDWATER, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia; e-mail:
[email protected] Dulal PANDA, Department of Biosciences and Bioengineering, Indian Institute of Technology Downloaded from Bombay, Mumbai 400076, India; e-mail:
[email protected] molpharm.aspetjournals.org Text pages: 26 Tables: 5 Figures: 14 at ASPET Journals on September 26, 2021 References: 39 Abstract: 232 words Introduction: 347 words Discussion: 796 words 2 Molecular Pharmacology Fast Forward. Published on April 2, 2020 as DOI: 10.1124/mol.119.118539 This article has not been copyedited and formatted.